Carlsmed Inc (CARL)

Currency in USD
13.70
+0.14(+1.03%)
Closed·
13.49-0.21(-1.53%)
·
Unusual trading volume
CARL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.4515.17
52 wk Range
8.5017.19
Key Statistics
Prev. Close
13.56
Open
13.9
Day's Range
13.45-15.17
52 wk Range
8.5-17.19
Volume
425.51K
Average Volume (3m)
173.87K
1-Year Change
12.7572%
Book Value / Share
3.45
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CARL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
18.60
Upside
+35.77%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to drop this year

Carlsmed Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 18.60
(+35.77% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Truist Securities
Buy20.00+45.99%18.00MaintainAug 06, 2026
Needham
Buy17.00+24.09%-New CoverageJul 01, 2026
Truist Securities
Buy18.00+31.39%20.00MaintainApr 15, 2026
BTIG
Buy23.00+67.88%24.00MaintainApr 13, 2026
Goldman Sachs
Buy17.00+24.09%19.00MaintainApr 09, 2026

Carlsmed Inc Earnings Call Summary for Q2/2026

  • Q2 revenue surged 57% YoY to $18.9M; gross margin expanded to 76.8% from 73.4% on lower manufacturing costs and improved efficiency.
  • Full-year 2026 revenue guidance raised to $74M-$78M, implying 50%+ growth; new CMS reimbursement codes expected to benefit 2027 and beyond.
  • Net loss widened to $10.5M from $6.8M as operating expenses jumped to $25.6M on increased sales, R&D, and administrative investments.
  • Shares flat at $13.56 post-earnings; Q4 2026 product launches include aprevo bi-lateral lumbar system and Corra Cervical Plating System.
  • Management targets gross margins approaching 80% within 24 months; cervical business now 10% of revenue with expansion continuing in H2 2026.
Last Updated: 05/08/2026, 22:26
Read Full Transcript

Earnings

Latest Release
Aug 05, 2026
EPS / Forecast
-0.39 / -0.39
Revenue / Forecast
18.94M / --
EPS Revisions
Last 90 days

CARL Income Statement

Compare CARL to Peers and Sector

Metrics to compare
CARL
Peers
Sector
Relationship
P/E Ratio
−10.2x−2.8x−0.4x
PEG Ratio
−0.15−0.320.00
Price/Book
4.4x5.1x2.6x
Price / LTM Sales
5.9x3.1x3.0x
Upside (Analyst Target)
32.7%58.7%50.7%
Fair Value Upside
Unlock−2.1%7.2%Unlock

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.21M11.79%43.46M
Other Institutional Investors
24.66M88.21%334.36M
Public Companies & Retail Investors
0.000.00%0.00
Total
27.86M100.00%377.83M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
B Capital Group Management, L.P.30.61%8,321,763112,843
B Capital Global Growth III, L.P.18.44%5,013,83967,988

People Also Watch

90.66
KLIC
-3.39%
171.12
AVAV
+1.82%
17.750
HSAI
-0.89%
230.43
CRDO
+2.58%

FAQ

What Is the Carlsmed (CARL) Stock Price Today?

The Carlsmed stock price today is 13.70 USD.

What Stock Exchange Does Carlsmed Trade On?

Carlsmed is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Carlsmed?

The stock symbol for Carlsmed is "CARL."

What Is the Carlsmed (CARL) Afterhours Price Today? (Afterhours variable test: 13.49) Current Date: Aug 07, 2026

After hours price: 13.49. After hours price change (units): -0.21. Price change percentage: -1.53%

What Is the Carlsmed Market Cap?

As of today, Carlsmed market cap is 372.43M USD.

What Is Carlsmed's Earnings Per Share (TTM)?

The Carlsmed EPS (TTM) is -1.64.

When Is the Next Carlsmed Earnings Date?

Carlsmed will release its next earnings report on Nov 05, 2026.

From a Technical Analysis Perspective, Is CARL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Carlsmed Stock Split?

Carlsmed has split 0 times.

How Many Employees Does Carlsmed Have?

Carlsmed has 127 employees.

What is the current trading status of Carlsmed (CARL)?

As of Aug 07, 2026, Carlsmed (CARL) is trading at a price of 13.70 USD, with a previous close of 13.56 USD. The stock has fluctuated within a day range of 13.45 USD to 15.17 USD, while its 52-week range spans from 8.50 USD to 17.19 USD.

What Is Carlsmed (CARL) Price Target According to Analysts?

The average 12-month price target for Carlsmed is 18.60 USD, with a high estimate of 23 USD and a low estimate of 17 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +35.77% Upside potential.

What Is the CARL Premarket Price?

CARL's last pre-market stock price is 13.87 USD. The pre-market share volume is 31.00, and the stock has decreased by 0.31, or 2.29%.

What Is the CARL After Hours Price?

CARL's last after hours stock price is 13.49 USD, the stock has decreased by -0.21, or -1.53%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.